D Lawrence Wickerham

Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial.

Norman Wolmark, Scott M Lippman, S. Reis, 2006, JAMA.

Estrogen receptor status of primary breast cancer is predictive of estrogen receptor status of contralateral breast cancer.

Norman Wolmark, S. Paik, J. Bryant, 2004, Journal of the National Cancer Institute.

Estrogen receptor (ESR1) mRNA expression and benefit from tamoxifen in the treatment and prevention of estrogen receptor-positive breast cancer.

Debora Fumagalli, Norman Wolmark, Soonmyung Paik, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Sequential preoperative or postoperative docetaxel added to preoperative doxorubicin plus cyclophosphamide for operable breast cancer:National Surgical Adjuvant Breast and Bowel Project Protocol B-27.

Norman Wolmark, Soonmyung Paik, S. Paik, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Predicting degree of benefit from adjuvant trastuzumab in NSABP trial B-31.

Jong-Hyeon Jeong, Hanna Bandos, Debora Fumagalli, 2013, Journal of the National Cancer Institute.

Predictors of locoregional recurrence after neoadjuvant chemotherapy: results from combined analysis of National Surgical Adjuvant Breast and Bowel Project B-18 and B-27.

Stewart J Anderson, Norman Wolmark, James J Dignam, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Real-world performance of HER2 testing--National Surgical Adjuvant Breast and Bowel Project experience.

Greg Yothers, Norman Wolmark, Soonmyung Paik, 2002, Journal of the National Cancer Institute.

Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis

Gideon Blumenthal, Nina Ditsch, David Cameron, 2014, The Lancet.

Tamoxifen, radiation therapy, or both for prevention of ipsilateral breast tumor recurrence after lumpectomy in women with invasive breast cancers of one centimeter or less.

Norman Wolmark, James J Dignam, Soonmyung Paik, 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Tamoxifen in treatment of intraductal breast cancer: National Surgical Adjuvant Breast and Bowel Project B-24 randomised controlled trial

James Dignam, Norman Wolmark, Mirsada Begovic, 1999, The Lancet.